# Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

> **NCT04360629** · NA · COMPLETED · sponsor: **Jun Zhang** · enrollment: 151 (actual)

## Conditions studied

- Advanced Ovarian Cancer

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT04360629
- **Lead sponsor:** Jun Zhang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-03
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04360629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04360629, "Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04360629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*